Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Discovery Laboratories begins phase II tyloxapol trial in cystic fibrosis

Aug. 6, 1999

Aeolus receives notice of allowance for U.S. patent covering synthetic SOD mimetics

Aug. 3, 1999

International patent recently published covering AstraZeneca PKC inhibitors

July 28, 1999

Heterocyclic compounds as potent and selective NK2 antagonists

July 28, 1999

BM-113: pharmacokinetics and metabolism in rats following oral and intravenous dosing

July 27, 1999

Benzazepines synthesized at Zambon useful as antiallergic/antiinflammatory agents

July 26, 1999

AstraZeneca claims new immunosuppressants for asthma, bronchitis, rhinitis, etc.

July 22, 1999

New antiasthmatic agent in the pipeline at Nikken Chemicals

July 22, 1999

Novel series of PDE4 inhibitors from Byk Gulden particularly useful for asthma prophylaxis

July 22, 1999

Genset seeks patents for two genes associated with zileuton-induced hepatotoxicity

July 22, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...